Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | LDHB | P07195 | 1/20 | 0.36 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL23581160 | 0.86 | LDHA (0.33) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL23581158 | 0.86 | LDHA (0.33) | CA1CA2CA9LDHALDHB | |
| Bicarbonate SCHEMBL691010 | 0.84 | — | — | |
| Oxalic Acid SCHEMBL29162166 | 0.82 | LDHA (0.31) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL19409115 | 0.82 | LDHA (0.31) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL19715294 | 0.79 | KDM5B (0.33) | KDM5B | |
| Oxalic Acid SCHEMBL31725588 | 0.79 | OR51E2 (0.32) | — | |
| Oxalic Acid SCHEMBL31738433 | 0.78 | — | — | |
| Oxalic Acid SCHEMBL11147627 | 0.78 | — | — | |
| Oxalic Acid SCHEMBL11211823 | 0.78 | CA1 (0.57) | CA1CA2CA9LDHALDHB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117586292-A | Lithium difluoro oxalate borate, and preparation method and application thereof | 香河昆仑新能源材料股份有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117586292-A | Lithium difluoro oxalate borate, and preparation method and application thereof | 香河昆仑新能源材料股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117586292-A | Lithium difluoro oxalate borate, and preparation method and application thereof | 香河昆仑新能源材料股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-106946775-A | A kind of compound and its application in anti-hepatitis C virus medicine is prepared | 清华大学 | 2017-07-14 | — | — | CN | disclosed |
| CN-104761524-A | Compounds and application thereof in preparation of anti-parasitosis drugs | UNIV TSINGHUA | 2015-07-08 | — | — | CN | disclosed |
| CN-104650028-A | Synthesis process for novel heliotropin monoester | CHENGDU JIANZHONG FLAVORS & FRAGRANCES CO LTD | 2015-05-27 | — | — | CN | disclosed |
| CN-101309917-B | Stomach H with enhanced therapeutic properties+，K+-deuteration inhibitors of ATPase | AUSPEX PHARMACEUTICALS INC | 2013-09-11 | — | — | CN | disclosed |
| CN-101605774-B | 2-methyl-3-(3,4-methylenedioxyphenyl)propanal, and method for production thereof | UBE INDUSTRIES | 2013-05-29 | — | — | CN | disclosed |
| CN-101622238-B | Method of retaining the quality of 2-methyl-3-(3,4-methylenedioxyphenyl)propanal and process for producing the same | UBE INDUSTRIES | 2013-05-29 | — | — | CN | disclosed |
| CN-101336226-B | Substituted phenethylamines with 5-hydroxytryptamine activity and/or norepinephrine activity | AUSPEX PHARMACEUTICALS INC | 2012-05-23 | — | — | CN | disclosed |
| CN-101687788-A | The indoles that replaces | AUSPEX PHARMACEUTICALS INC | 2010-03-31 | — | — | CN | disclosed |
| CN-101622238-A | Method of retaining the quality of 2-methyl-3-(3,4-methylenedioxyphenyl)propanal and process for producing the same | UBE INDUSTRIES | 2010-01-06 | — | — | CN | disclosed |
| CN-101605774-A | 2-methyl-3-(3, the 4-methylene dioxy phenyl group) propionic aldehyde and manufacture method thereof | UBE INDUSTRIES (JP) | 2009-12-16 | — | — | CN | disclosed |
| CN-101360698-A | Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity | AUSPEX PHARMACEUTICALS INC (US) | 2009-02-04 | — | — | CN | disclosed |
| CN-101360742-A | Substituted phenylpiperidines with serotonin-derived activity and enhanced therapeutic properties | AUSPEX PHARMACEUTICALS INC (US) | 2009-02-04 | — | — | CN | disclosed |
| CN-101336226-A | Substituted phenethylamines with 5-hydroxytryptamine activity and/or norepinephrine activity | AUSPEX PHARMACEUTICALS INC (US) | 2008-12-31 | — | — | CN | disclosed |
| CN-101309917-A | Stomach H with enhanced therapeutic properties+，K+-deuteration inhibitors of ATPase | AUSPEX PHARMACEUTICALS INC (US) | 2008-11-19 | — | — | CN | disclosed |
| CN-1882548-A | pH-sensitive prodrugs of 2, 6-diisopropylphenol | AUSPEX PHARMACEUTICALS INC (US) | 2006-12-20 | — | — | CN | disclosed |